Brief: Context Therapeutics Files For Resale Of Up To 10 Million Shares Of Common Stock By Selling Stockholders - SEC Filing
Dec 10 (Reuters) - Context Therapeutics Inc CNTX.O :
* CONTEXT THERAPEUTICS FILES FOR RESALE OF UP TO 10 MILLION
SHARES
OF COMMON STOCK BY SELLING STOCKHOLDERS - SEC FILING
Source text for Eikon: [https://bit.ly/3q4Euwj]
Further company coverage: CNTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Context Therapeutics
See all newsContext Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Context Therapeutics Q2 net loss widens on higher R&D costs
Context Therapeutics Inc expected to post a loss of 9 cents a share - Earnings Preview
Brief: Context Therapeutics Announces Positive Interim Efficacy And Safety Results From Ongoing Phase 1 Clinical Trial For CTIM-76
Brief: Context Therapeutics Enters Into License Agreement Amendment With BioAtla For CT-202